Prazosin in PTSD

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 4, 2003, Pages 384-385

  Brkanac, Zoran ^a   Pastor, John F ^a   Storck, Michael ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PRAZOSIN;

ADOLESCENT; CASE REPORT; FEMALE; HUMAN; LETTER; POSTTRAUMATIC STRESS DISORDER;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; FEMALE; HUMANS; PRAZOSIN; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0037984264     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/01.CHI.0000052509.98293.97     Document Type: Letter

References (4)

1. American Academy of Child and Adolescent Psychiatry (1998), Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 37(suppl): 4S-26S
2. Good C, Petersen C (2001), SSRI and mirtazapine in PTSD. J Am Acad Child Adolesc Psychiatry 40:263-264
3. Southwick SM, Bremner JD, Rasmusson A, Morgan 3rd, CA Arnsten A, Charney DS (1999), Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46:1192-1204
4. Taylor F, Raskind MA (2002), The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol 22:82-85